| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| CD274 | CD28 | ENSSSCP00000005602 | ENSSSCP00000071532 | CD274 molecule. | IGv domain-containing protein. | 0.731 |
| CD274 | CD4 | ENSSSCP00000005602 | ENSSSCP00000019155 | CD274 molecule. | CD4 molecule. | 0.809 |
| CD274 | CD40 | ENSSSCP00000005602 | ENSSSCP00000052319 | CD274 molecule. | Tumor necrosis factor receptor superfamily member 5; Receptor for TNFSF5/CD40LG (By similarity). Transduces TRAF6- and MAP3K8-mediated signals that activate ERK in macrophages and B cells, leading to induction of immunoglobulin secretion (By similarity). | 0.608 |
| CD274 | CD40LG | ENSSSCP00000005602 | ENSSSCP00000020229 | CD274 molecule. | CD40 ligand, membrane form; Cytokine that acts as a ligand to CD40/TNFRSF5 (By similarity). Costimulates T-cell proliferation and cytokine production (By similarity). Its cross-linking on T-cells generates a costimulatory signal which enhances the production of IL4 and IL10 in conjunction with the TCR/CD3 ligation and CD28 costimulation (By similarity). Induces the activation of NF-kappa-B (By similarity). Induces the activation of kinases MAPK8 and PAK2 in T-cells (By similarity). Mediates B-cell proliferation in the absence of co-stimulus as well as IgE production in the presence of [...] | 0.458 |
| CD274 | CD80 | ENSSSCP00000005602 | ENSSSCP00000012679 | CD274 molecule. | CD80 molecule. | 0.995 |
| CD274 | CD86 | ENSSSCP00000005602 | ENSSSCP00000028828 | CD274 molecule. | T-lymphocyte activation antigen CD86 isoform 1. | 0.675 |
| CD274 | CTLA4 | ENSSSCP00000005602 | ENSSSCP00000031088 | CD274 molecule. | Cytotoxic T-lymphocyte protein 4; Inhibitory receptor acting as a major negative regulator of T-cell responses. The affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28. | 0.740 |
| CD274 | IFNG | ENSSSCP00000005602 | ENSSSCP00000036242 | CD274 molecule. | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons; Belongs to the type II (or gamma) interferon family. | 0.683 |
| CD274 | IL10 | ENSSSCP00000005602 | ENSSSCP00000016594 | CD274 molecule. | Interleukin-10; Major immune regulatory cytokine that acts on many cells of the immune system where it has profound anti-inflammatory functions, limiting excessive tissue disruption caused by inflammation. Mechanistically, IL10 binds to its heterotetrameric receptor comprising IL10RA and IL10RB leading to JAK1 and STAT2-mediated phosphorylation of STAT3. In turn, STAT3 translocates to the nucleus where it drives expression of anti-inflammatory mediators. Targets antigen-presenting cells (APCs) such as macrophages and monocytes and inhibits their release of pro-inflammatory cytokines in [...] | 0.660 |
| CD28 | CD274 | ENSSSCP00000071532 | ENSSSCP00000005602 | IGv domain-containing protein. | CD274 molecule. | 0.731 |
| CD28 | CD4 | ENSSSCP00000071532 | ENSSSCP00000019155 | IGv domain-containing protein. | CD4 molecule. | 0.882 |
| CD28 | CD40 | ENSSSCP00000071532 | ENSSSCP00000052319 | IGv domain-containing protein. | Tumor necrosis factor receptor superfamily member 5; Receptor for TNFSF5/CD40LG (By similarity). Transduces TRAF6- and MAP3K8-mediated signals that activate ERK in macrophages and B cells, leading to induction of immunoglobulin secretion (By similarity). | 0.756 |
| CD28 | CD40LG | ENSSSCP00000071532 | ENSSSCP00000020229 | IGv domain-containing protein. | CD40 ligand, membrane form; Cytokine that acts as a ligand to CD40/TNFRSF5 (By similarity). Costimulates T-cell proliferation and cytokine production (By similarity). Its cross-linking on T-cells generates a costimulatory signal which enhances the production of IL4 and IL10 in conjunction with the TCR/CD3 ligation and CD28 costimulation (By similarity). Induces the activation of NF-kappa-B (By similarity). Induces the activation of kinases MAPK8 and PAK2 in T-cells (By similarity). Mediates B-cell proliferation in the absence of co-stimulus as well as IgE production in the presence of [...] | 0.867 |
| CD28 | CD80 | ENSSSCP00000071532 | ENSSSCP00000012679 | IGv domain-containing protein. | CD80 molecule. | 0.999 |
| CD28 | CD86 | ENSSSCP00000071532 | ENSSSCP00000028828 | IGv domain-containing protein. | T-lymphocyte activation antigen CD86 isoform 1. | 0.998 |
| CD28 | CTLA4 | ENSSSCP00000071532 | ENSSSCP00000031088 | IGv domain-containing protein. | Cytotoxic T-lymphocyte protein 4; Inhibitory receptor acting as a major negative regulator of T-cell responses. The affinity of CTLA4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28. | 0.648 |
| CD28 | IFNG | ENSSSCP00000071532 | ENSSSCP00000036242 | IGv domain-containing protein. | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons; Belongs to the type II (or gamma) interferon family. | 0.812 |
| CD28 | IL10 | ENSSSCP00000071532 | ENSSSCP00000016594 | IGv domain-containing protein. | Interleukin-10; Major immune regulatory cytokine that acts on many cells of the immune system where it has profound anti-inflammatory functions, limiting excessive tissue disruption caused by inflammation. Mechanistically, IL10 binds to its heterotetrameric receptor comprising IL10RA and IL10RB leading to JAK1 and STAT2-mediated phosphorylation of STAT3. In turn, STAT3 translocates to the nucleus where it drives expression of anti-inflammatory mediators. Targets antigen-presenting cells (APCs) such as macrophages and monocytes and inhibits their release of pro-inflammatory cytokines in [...] | 0.676 |
| CD4 | CD274 | ENSSSCP00000019155 | ENSSSCP00000005602 | CD4 molecule. | CD274 molecule. | 0.809 |
| CD4 | CD28 | ENSSSCP00000019155 | ENSSSCP00000071532 | CD4 molecule. | IGv domain-containing protein. | 0.882 |
